Lao H Saal
Lao H Saal
Associate Professor, Lund University
Verified email at med.lu.se - Homepage
Title
Cited by
Cited by
Year
Classification and diagnostic prediction of cancers using gene expression profiling and artificial neural networks
J Khan, JS Wei, M Ringner, LH Saal, M Ladanyi, F Westermann, ...
Nature Medicine 7 (6), 673-679, 2001
31322001
PIK3CA mutations correlate with hormone receptors, node metastasis, and ERBB2, and are mutually exclusive with PTEN loss in human breast carcinoma
LH Saal, K Holm, M Maurer, L Memeo, T Su, X Wang, SY Jennifer, ...
Cancer Research 65 (7), 2554-2559, 2005
9502005
Estrogen receptor status in breast cancer is associated with remarkably distinct gene expression patterns
S Gruvberger, M Ringnér, Y Chen, S Panavally, LH Saal, Ĺ Borg, M Fernö, ...
Cancer Research 61 (16), 5979-5984, 2001
8472001
The CD44+/CD24-phenotype is enriched in basal-like breast tumors
G Honeth, PO Bendahl, M Ringnér, LH Saal, SK Gruvberger-Saal, ...
Breast Cancer Research 10 (3), 1-12, 2008
5852008
Poor prognosis in carcinoma is associated with a gene expression signature of aberrant PTEN tumor suppressor pathway activity
LH Saal, P Johansson, K Holm, SK Gruvberger-Saal, QB She, M Maurer, ...
Proceedings of the National Academy of Sciences 104 (18), 7564-7569, 2007
5532007
BioArray Software Environment (BASE): a platform for comprehensive management and analysis of microarray data
LH Saal, C Troein, J Vallon-Christersson, S Gruvberger, Ĺ Borg, ...
Genome biology 3 (8), 1-6, 2002
5402002
Recurrent gross mutations of the PTEN tumor suppressor gene in breast cancers with deficient DSB repair
LH Saal, SK Gruvberger-Saal, C Persson, K Lövgren, M Jumppanen, ...
Nature Genetics 40 (1), 102-107, 2007
3802007
cDNA microarrays detect activation of a myogenic transcription program by the PAX3-FKHR fusion oncogene
J Khan, ML Bittner, LH Saal, U Teichmann, DO Azorsa, GC Gooden, ...
Proceedings of the National Academy of Sciences 96 (23), 13264-13269, 1999
3771999
Serial monitoring of circulating tumor DNA in patients with primary breast cancer for detection of occult metastatic disease
E Olsson, C Winter, A George, Y Chen, J Howlin, MHE Tang, M Dahlgren, ...
EMBO molecular medicine 7 (8), 1034-1047, 2015
2762015
Expression profiling in cancer using cDNA microarrays
J Khan, LH Saal, ML Bittner, Y Chen, JM Trent, PS Meltzer
ELECTROPHORESIS: An International Journal 20 (2), 223-229, 1999
2521999
Activation of the PI3K pathway in cancer through inhibition of PTEN by exchange factor P-REX2a
B Fine, C Hodakoski, S Koujak, T Su, LH Saal, M Maurer, B Hopkins, ...
Science 325 (5945), 1261, 2009
2192009
Estrogen receptor β expression is associated with tamoxifen response in ERα-negative breast carcinoma
SK Gruvberger-Saal, PO Bendahl, LH Saal, M Laakso, C Hegardt, P Edén, ...
Clinical Cancer Research 13 (7), 1987-1994, 2007
2062007
CD44 isoforms are heterogeneously expressed in breast cancer and correlate with tumor subtypes and cancer stem cell markers
E Olsson, G Honeth, PO Bendahl, L Saal, S Gruvberger-Saal, M Ringnér, ...
BMC Cancer 11 (1), 418, 2011
1852011
Global H3K27 trimethylation and EZH2 abundance in breast tumor subtypes
K Holm, D Grabau, K Lövgren, S Aradottir, S Gruvberger-Saal, J Howlin, ...
Molecular oncology 6 (5), 494-506, 2012
1382012
3-Phosphoinositide–dependent kinase 1 potentiates upstream lesions on the phosphatidylinositol 3-kinase pathway in breast carcinoma
M Maurer, T Su, LH Saal, S Koujak, BD Hopkins, CR Barkley, J Wu, ...
Cancer Research 69 (15), 6299-6306, 2009
1302009
Molecular stratification of metastatic melanoma using gene expression profiling: Prediction of survival outcome and benefit from molecular targeted therapy
H Cirenajwis, H Ekedahl, M Lauss, K Harbst, A Carneiro, J Enoksson, ...
Oncotarget 6 (14), 12297, 2015
942015
Targeted sequencing of BRCA1 and BRCA2 across a large unselected breast cancer cohort suggests that one-third of mutations are somatic
C Winter, MP Nilsson, E Olsson, AM George, Y Chen, A Kvist, T Törngren, ...
Annals of Oncology 27 (8), 1532-1538, 2016
732016
Microenvironmental control of breast cancer subtype elicited through paracrine platelet-derived growth factor-CC signaling
P Roswall, M Bocci, M Bartoschek, H Li, G Kristiansen, S Jansson, S Lehn, ...
Nature medicine 24 (4), 463, 2018
682018
The Sweden Cancerome Analysis Network-Breast (SCAN-B) Initiative: a large-scale multicenter infrastructure towards implementation of breast cancer genomic analyses in the …
LH Saal, J Vallon-Christersson, J Häkkinen, C Hegardt, D Grabau, ...
Genome medicine 7 (1), 1-12, 2015
672015
NF1‐mutated melanoma tumors harbor distinct clinical and biological characteristics
H Cirenajwis, M Lauss, H Ekedahl, T Törngren, A Kvist, LH Saal, H Olsson, ...
Molecular oncology 11 (4), 438-451, 2017
612017
The system can't perform the operation now. Try again later.
Articles 1–20